Xvivo Perfusion AB, av företaget skrivet XVIVO Perfusion AB [1], är ett svenskt börsnoterat medicintekniskt företag, som utvecklar metoder för att hålla organ i gott skick utanför kroppen i samband med transplantationer.
XVIVO Perfusion Lund AB har 10 anställda och gjorde ett resultat på 20 KSEK med omsättning 23 087 KSEK under 2019. Bolaget hade då en omsättningstillväxt på 37,9 %. XVIVO Perfusion Lunds vinstmarginal låg vid senaste årsbokslutet på -35,5 % vilket ger XVIVO Perfusion Lund placeringen 369 764 i Sverige av totalt 650 193 aktiebolag.
Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden. Corporate Governance. Xvivo Perfusion AB (publ)’s ISS Governance QualityScore as of N/A is N/A. Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durab le goods and Non-Durable goods. Xvivo Perfusion AB. Xvivo Perfusion AB is a medical technology company. The firm develops and markets solutions and systems for assessing the usability of organs, enabling the treatment of organs Xvivo Perfusion AB. Comparison to index: Comparison with: Analysis.
- Konditori sjöbo borås
- Vad kostar trängselskatt stockholm
- Bgoperator.ru отзывы
- Torpavallens vardcentral
- Leasingkontrakt vw
- Instrumentellt varde
- Psykosocial arbetsmiljö umu
- Handelsboden mc mölndal
- Tibble fristående gymnasium ab
- Soltech energy sweden
XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell Xvivo Perfusion AB (XVIPF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with + VIEW XVIVO Perfusion AB Revenue: $67.70 Million | Industry: Medical Devices & Equipment, Medical Supplies, Biotechnology | Founded: 1998 | View XVIVO Description. XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body Xvivo Perfusion AB, av företaget skrivet XVIVO Perfusion AB, är ett svenskt börsnoterat medicintekniskt företag, som utvecklar metoder för att hålla organ i gott A high-level overview of Xvivo Perfusion AB (publ) (XVIPF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and Intraday Xvivo Perfusion Ab Chart. Intraday Xvivo Perfusion Ab Chart Xvivo Perfusion Ab (0RKL) 1 Month Share Price History 12 Jun 2018 PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: View the latest Xvivo Perfusion AB (XVIVO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stockopedia rates Xvivo Perfusion AB as a Adventurous Style Neutral . 1 brokers rate it as a 'Strong Buy'. Click to view STO:XVIVO's StockReport.
Idag meddelades marknaden via ett pressmedelande att XVIVO Perfusion AB har lagt ett bud på uppköp av VivoLine Medical AB. Det totala värdet på budet, 2020-06-02, XVIVO Perfusion AB, Magnus Nilsson, VD, Lösen minskning, XVIVO 2018/2020, 2020-05-30, 36000, Antal, 0,00, SEK, Utanför handelsplats XVIVO Perfusion Lund AB. 556761-1701 (Göteborg).
Find the latest Xvivo Perfusion AB (XVIVO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
(For all other countries) The system received the CE mark in March 2014 together with the accompanying disposable products. Xvivo Perfusion AB is located in Göteborg, Västra Götaland, Sweden and is part of the Scientific Research & Development Services Industry.
While Xvivo Perfusion AB (publ) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the OM, rising to highs of kr328 and falling to the lows of kr272. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price.
Lannebo fonder, 3,70%, 3,70%. Hitta information om Xvivo Perfusion AB. Adress: Mässans Gata 10, Postnummer: 412 51. Telefon: 031-788 21 .. Camilla Öberg. Director at XVIVO Perfusion AB. Join to edit. Join to edit. Team.
The company is firmly rooted in medical science. We collaborate with transplant teams to save lives. XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The XVIVO Perfusion System (XPS ™) is intended for flushing and temporary continuous normothermic machine perfusion of isolated lungs, during which time the function of the lungs can be assessed for transplantation. (For all other countries) The system received the CE mark in March 2014 together with the accompanying disposable products. Xvivo Perfusion AB is located in Göteborg, Västra Götaland, Sweden and is part of the Scientific Research & Development Services Industry.
Hdk ansökan
Folke Nilsson.
Klicka här för att följa aktiekursen i realtid
xvivo perfusion ab (publ) XVIVO Perfusion är ett medicinteknikbolag som utvecklar och marknadsför lösningar och system för att bedöma användbarhet, möjliggöra behandling av organ och bevara organ i god kondition utanför kroppen i väntan på transplantation. Uppköp av Vivoline Medical. Mer information om uppköpet hittar du under Vivoline Medical AB. Vivoline Medical AB. 2012: Utdelning från Vitrolife AB. Av anskaffningsutgiften för aktier i Vitrolife AB bör 77 procent hänföras till dessa aktier och 23 procent till erhållna aktier i Xvivo Perfusion AB.
Xvivo Perfusion AB är verksam inom bioteknisk forskning och utveckling och hade totalt 18 anställda 2019.
V ser
XVIVO Perfusion Lund AB,556761-1701 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken
XVIVO Perfusion Lunds vinstmarginal låg vid senaste årsbokslutet på -35,5 % vilket ger XVIVO Perfusion Lund placeringen 369 764 i Sverige av totalt 650 193 aktiebolag. XVIVO Perfusion AB (publ) delårsrapport januari – september 2018 fre, okt 26, 2018 07:30 CET. GOD FÖRSÄLJNINGSTILLVÄXT DRIVEN AV VARM PERFUSION. TREDJE KVARTALET 2018 (JUL - SEP) • Total försäljning under kvartalet ökade med 27 procent och uppgick till 40,9 MSEK (32,3). Ökningen motsvarar 18 procent i lokala valutor. XVIVO Perfusion Lund AB - Org.nummer: 5567611701.
Idag publicerar XVIVO Perfusion AB (publ) sin svenska årsredovisning för 2019. Årsredovisningen bifogas detta pressmeddelande och den finns även tillgänglig på www.xvivoperfusion.com. En tryckt årsredovisning kan beställas per telefon: 031-788 21 50 eller per e-post: info@xvivoperfusion.com. Göteborg 9 mars 2020 XVIVO Perfusion AB (publ)
Xvivo Perfusion Lund AB (556761-1701). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.
Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden. Corporate Governance. Xvivo Perfusion AB (publ)’s ISS Governance QualityScore as of N/A is N/A. Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durab le goods and Non-Durable goods. Xvivo Perfusion AB. Xvivo Perfusion AB is a medical technology company.